The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of HER2-ultralow heterogeneity and optimal threshold on trastuzumab deruxtecan (T-DXd) efficacy in metastatic breast cancer: A national multicenter cohort study (HEROIC).
 
Yutian Zou
No Relationships to Disclose
 
Xinpei Deng
No Relationships to Disclose
 
Yuan Zeng
No Relationships to Disclose
 
Xiaoqian Hu
No Relationships to Disclose
 
Quchang Ouyang
No Relationships to Disclose
 
Qianjun Chen
No Relationships to Disclose
 
Peijian Peng
No Relationships to Disclose
 
Tao Wu
No Relationships to Disclose
 
Weiwei Huang
No Relationships to Disclose
 
Shien Cui
No Relationships to Disclose
 
Jianchun Gu
No Relationships to Disclose
 
Caiwen Du
No Relationships to Disclose
 
Hongsheng Li
No Relationships to Disclose
 
Yingkuan Shao
No Relationships to Disclose
 
Xiaoxiang Guan
No Relationships to Disclose
 
Xiu-Mei Wang
No Relationships to Disclose
 
Hong Hu
No Relationships to Disclose
 
Xiaoyu Chen
No Relationships to Disclose
 
Wenjun Yi
No Relationships to Disclose
 
Xiaoming Xie
No Relationships to Disclose
 
The HEROIC Study Investigator Group
No Relationships to Disclose